Related Experiment Video
Updated: Dec 20, 2025

08:12
Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases
Published on: October 4, 2024
2.3K
Exercise efficiency impairment in metabolic myopathies.
Jean-Baptiste Noury1, Fabien Zagnoli1, François Petit2
1Neurology Department, Neuromuscular Center, CHRU Cavale Blanche, Brest, F-29609, France.
Scientific Reports
|May 31, 2020
Summary
Metabolic myopathies increase the body's oxygen cost during exercise, meaning patients perform less work for the same oxygen consumed. This finding highlights a key physiological difference in these muscle disorders.
Area of Science:
- Exercise Physiology
- Neuromuscular Disorders
- Biochemistry
Background:
- Metabolic myopathies are genetic disorders affecting skeletal muscle energy production, leading to exercise intolerance.
- Understanding the physiological consequences, such as oxygen cost, is crucial for diagnosis and management.
Purpose of the Study:
- To evaluate the oxygen cost (∆V'O2/∆Work-Rate) during incremental exercise in patients with various metabolic myopathies.
- To compare these metabolic myopathy patients with those experiencing non-metabolic myalgia and healthy individuals.
Main Methods:
- Cardiopulmonary exercise testing (CPX) was performed on a bicycle ergometer.
- Pulmonary oxygen consumption (V'O2) was measured breath-by-breath.
- The oxygen cost (∆V'O2/∆Work-Rate slope) was determined using linear regression analysis.
Main Results:
- Patients with glycogenoses and respiratory chain defects showed significantly lower peak oxygen consumption compared to controls.
- The oxygen cost (∆V'O2/∆Work-Rate slope) was elevated in patients with myoadenylate deaminase (MAD) deficiency, glycogenoses, respiratory chain defects, and non-metabolic myalgia compared to controls.
- This indicates a higher metabolic demand for a given workload in these patient groups.
Conclusions:
- Patients with metabolic myopathies exhibit an increased oxygen cost during exercise.
- This heightened oxygen cost results in reduced work capacity for a given oxygen uptake during daily activities.
- The findings underscore the significant impact of metabolic defects on exercise efficiency in muscle disorders.
More Related Videos
Related Concept Videos
Muscle Recovery and Fatigue
3.8K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
3.8K
Disorders of the Skeletal Muscle
1.6K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
Myasthenia Gravis: Diagnostic Tests
1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Myasthenia Gravis: Overview and Treatment
2.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K

